United Kingdom· GB-APID-32685411000001109
Obizur 500unit powder and solvent for solution for injection vials
A susoctocog alfa product containing susoctocog alfa, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Susoctocog alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD14 (susoctocog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Susoctocog alfa · ATC B02BD14
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Susoctocog alfa
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD14
- ATC class
- Susoctocog alfa
- Defined daily dose
- 14 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 7
- gtin00642621027587
- gtin00642621071207
- gtin00642621077735
- gtin00642621027594
- gtin00642621071214
- gtin00642621027600
- gtin00642621071221
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Susoctocog alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOBIZURBaxalta Innovations GmbH, Vídeň
- SpainOBIZUR 500 U POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBaxalta Innovations Gmbh
- FinlandObizurBaxalta Innovations GmbH
- FranceOBIZUR 500 U, poudre et solvant pour solution injectableBAXALTA INNOVATIONS (AUTRICHE)
- IrelandOBIZUR 500 U powder and solvent for solution for injectionBaxter Innovations GmbH
- IcelandObizurBaxalta Innovations GmbH
- Japanスソクトコグ アルファ（遺伝子組換え）武田薬品工業
- NetherlandsObizur 500 U poeder en oplosmiddel voor oplossing voor injectieBaxter Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Obizur
- Liechtenstein · Obizur
- Norway · Obizur
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/384410cf-c081-4813-b5ac-976cc935fa70 GET /v1/drugs/384410cf-c081-4813-b5ac-976cc935fa70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "32685411000001109",
"desc": "Obizur 500unit powder and solvent for solution for injection vials (Takeda UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "32685311000001102",
"source": "dmd",
"vtm_id": "32687311000001105",
"strength": "500 unit",
"substance": "Susoctocog alfa",
"ingredient": "Susoctocog alfa",
"supplier_code": "3811601000001107"
}See everything about susoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.